References
- Curl L, Sampson W. The presence of TNF-alpha and TNFR1 in aseptic root resorption. A preliminary study. Aust Orthod J 2011;27:102-9.
- Hill PA. Bone remodelling. Br J Orthod 1998;25:101-7.
- Hadjidakis DJ, Androulakis II. Bone remodeling. Ann N Y Acad Sci 2006;1092:385-96.
- Phan TC, Xu J, Zheng MH. Interaction between osteoblast and osteoclast: impact in bone disease. Histol Histopathol 2004;19:1325-44.
- Takayanagi H. Mechanistic insight into osteoclast differentiation in osteoimmunology. J Mol Med (Berl) 2005;83:170-9.
- Wise GE, Yao S, Zhang Q, Ren Y. Inhibition of osteoclastogenesis by the secretion of osteoprotegerin in vitro by rat dental follicle cells and its implication for tooth eruption. Arch Oral Biol 2002;47:247-54.
- Wada N, Maeda H, Yoshimine Y, Akamine A. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha. Bone 2004;35:629-35.
- Yun TJ, Chaudhary PM, Shu GL, Frazer JK, Ewings MK, Schwartz SM et al. OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. J Immunol 1998;161:6113-21.
- Simonet WS, Lacey DL, Dunstan CR, Kelly M, Chang MS, Lüthy R et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997;89:309-19.
- Tsuda E, Goto M, Mochizuki S, Yano K, Kobayashi F, Morinaga T et al. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 1997;234:137-42.
- Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedt T et al. RANK is essential for osteoclast and lymph node development. Genes Dev 1999;13:2412-24.
- Kim N, Odgren PR, Kim DK, Marks SC Jr, Choi Y. Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene. Proc Natl Acad Sci USA 2000;97:10905-10.
- Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999;397:315-23.
- Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL et al. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA 2000;97:1566-71.
- Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998;12:1260-8.
- Mizuno A, Amizuka N, Irie K, Murakami A, Fujise N, Kanno T et al. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem Biophys Res Commun 1998;247:610-5.
- Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997;89:309-19.
- Nanci A, Bosshardt DD. Structure of periodontal tissues in health and disease. Periodontol 2000 2006;40:11-28.
- Biederman W. Etiology and treatment of tooth ankylosis. Amer J Orthod 1962;48:670-84.
- Nakamura Y, Tanaka T, Kuwahara Y. New findings in the degenerating tissues of the periodontal ligament during experimental tooth movement. Am J Orthod Dentofacial Orthop 1996;109:348-54.
- Andreasen JO. Analysis of pathogenesis and topography of replacement root resorption (ankylosis) after replantation of mature permanent incisors in monkeys. Swed Dent J 1980;4:231-40.
- Loe H, Waerhaug J. Experimental replantation of teeth in dogs and monkeys. Arch Oral Biol 1961;3:176-84.
- Natiella JR, Armitage JE, Greene GW. The replantation and transplantation of teeth: A review. Oral Surg Oral Med Oral Pathol 1970;29:397-419.
- Birkedal-Hansen H. External root resorption caused by luxation of rat molars. Scand J Dent Res 1973;81:47-61.
- Madden TE, Caton JG. Animal models for periodontal disease. Methods Enzymol 1994;235:106-19.
- Ren Y, Maltha JC, Kuijpers-Jagtman AM. The rat as a model for orthodontic tooth movement--a critical review and a proposed solution. Eur J Orthod 2004;26:483-90.
- Grzesik WJ, Narayanan AS. Cementum and periodontal wound healing and regeneration. Crit Rev Oral Biol Med 2002;13:474-84.
- Dreyer CW. Clast cell activity in a model of aseptic root resorption. PhD thesis. Adelaide: The University of Adelaide, 2002.
- Andreasen JO. A time-related study of periodontal healing and root resorption activity after replantation of mature permanent incisors in monkeys. Swed Dent J 1980;4:101-10.
- Cardaropoli G, Araújo M, Lindhe J. Dynamics of bone tissue formation in tooth extraction sites: An experimental study in dogs. J Clin Periodontol 2003;30:809-18.
- Doherty MJ, Ashton BA, Walsh S, Beresford JN, Grant ME, Canfield AE. Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Miner Res 1998;13:828-38.
- Andreasen JO, Skougaard MR. Reversibility of surgically induced dental ankylosis in rats. Int J Oral Surg 1972;1:98-102.
- Hammarström L, Blomlöf L, Lindskog S. Dynamics of dentoalveolar ankylosis and associated root resorption. Endod Dent Traumatol 1989;5:163-75.
- Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-76.
- Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 1999;96:3540-5.
- Kawamoto S, Ejiri S, Nagaoka E, Ozawa H. Effects of oestrogen deficiency on osteoclastogenesis in the rat peiodontium. Arch Oral Biol 2002;47:67-73.
- Kawamoto S, Ejiri S, Hoshi K, Nagaoka E, Ozawa H. Immunolocalization of osteoclast differentiation factor in rat periodontium. Arch Oral Biol 2002;47:55-8.
- Wada N, Maeda H, Tanabe K, Tsuda E, Yano K, Nakamuta H et al. Periodontal ligament cells secrete the factor that inhibits osteoclastic differentiation and function: the factor is osteoprotegerin/osteoclastogenesis inhibitory factor. J Periodontal Res 2001;36:56-63.
- Collin-Osdoby P. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ Res 2004;95:1046-57.
- Crotti T, Smith MD, Hirsch R, Soukoulis S, Weedon H, Capone M et al. Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. J Periodontal Res 2003;38:380-7.
- Zhu WQ, Wang X, Wang XX, Wang ZY. Temporal and spatial expression of osteoprotegerin and receptor activator of nuclear factor -kappaB ligand during mandibular distraction in rats. J Craniomaxillofac Surg 2007;35:103-11.
- Fuller K, Murphy C, Kirstein B, Fox SW, Chambers TJ. TNFalpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 2002;143:1108-18.
- Itonaga I, Sabokbar A, Sun SG, Kudo O, Danks L, Ferguson D et al. Transforming growth factor-beta induces osteoclast formation in the absence of RANKL. Bone 2004;34:57-64.